Madison, Wisconsin, United States
I lead by simplifying the complex. How? Through technical and business acumen, customer insight driven strategic analysis, cross-functional team building, prioritization, and focus on results. A strong scientific background fueled by incessant intellectual curiosity drives client engagement, relationship building and the ability to spur sales or close on negotiations.
Southern Research (SR) established in 1941, is a not-for-profit, 501(c)(3) research organization and was the first independent scientific research center in the Southeast. Headquartered in Alabama, SR is conducting basic and applied research in the areas of drug discovery, preclinical drug development, and clinical sample testing. Southern Research is an incorporated affiliate of the University of Alabama at Birmingham, and the two institutions are brought together through a shared belief in the power and potential of collaborative research. SR has led the discovery and development of several FDA approved oncology drugs (lomustine, carmustine, dacarbazine, fludarabine, and clofarabine) and one cytoprotective agent (Ethyol).
Mirus Bio, now part of MilliporeSigma of Merck KGaA, has provided the very best nucleic acid delivery solutions to customers since 1995 | Strategic Business Development and building of collaborative relationships with internal and external customers to drive operating revenue and financial objectives. Providing a consistent trajectory for growth through oversight of commercial operations.
Guided product development activities from ideation through launch and commercialization. Traveled extensively domestically and internationally to expand brand presence, engage customers through presentations and technical discussions, and provide quantifiable channel partner growth. Negotiated and executed agreements with key commercial partners.
EMD Biosciences, Inc. (became EMD Chemicals, Inc. and now MilliporeSigma) is an affiliate of Merck KGaA, Darmstadt, Germany | Supported efforts in a field-based role upon closure of the EMD Madison, Wisconsin site. Was responsible for technology assessment and evaluation of potential acquisition targets. Built comprehensive financial models for licensing, negotiated and closed on agreements with key commercial partners.
Increasing levels of responsibility within the Bioscience division of EMD Chemicals. Oversaw assay development efforts in Madison, Wisconsin and San Diego, California. Served as the Project Lead for the introduction of WideScreen Assays (now MILLIPLEX) on the Luminex xMAP platform. Responsibilities included inter-departmental oversight, negotiation and relationship management with key industry partners, commercialization and field sales support.
Diabetes research within the Endocrinology Group. Studied PEK/PERK stress response and PPAR signaling and thiazolidinedione effects on glucose transport.